- Conditions
- Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +7 more
- Locations
-
- Altana/Nycomed San Antonio, Texas, United States
Clinical trial condition
Rhinitis, Allergic, Perennial
Explore clinical trials studying Rhinitis, Allergic, Perennial. Study availability and eligibility vary by location and protocol.
68 public trials
0 recruiting studies
Rhinitis, Allergic, Perennial trial results
- Conditions
- Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +7 more
- Locations
-
- Altana/Nycomed Encinitas, California, United States
- Altana/Nycomed Los Angeles, California, United States
- Altana/Nycomed Mission Viejo, California, United States
- Altana/Nycomed San Diego, California, United States
NCT00224523
- Conditions
- Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +7 more
- Locations
-
- GSK Investigational Site Leuven, Belgium
- GSK Investigational Site Amsterdam, Netherlands
- GSK Investigational Site Nijmegen, Netherlands
- GSK Investigational Site The Hague, Netherlands
NCT00103454
- Conditions
- Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +7 more
- Locations
-
- GSK Investigational Site Little Rock, Arkansas, United States
- GSK Investigational Site Los Angeles, California, United States
- GSK Investigational Site Mission Viejo, California, United States
- GSK Investigational Site Orange, California, United States
NCT00107757
- Conditions
- Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +8 more
- Locations
-
- GSK Investigational Site Scottsdale, Arizona, United States
- GSK Investigational Site Little Rock, Arkansas, United States
- GSK Investigational Site Costa Mesa, California, United States
- GSK Investigational Site Cudahy, California, United States
Completed
A Study of GW685698X for the Treatment Of Perennial Allergic Rhinitis in Adolescents and Adults
NCT00116818
- Conditions
- Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +7 more
- Locations
-
- GSK Investigational Site San Antonio, Texas, United States
- GSK Investigational Site Mississauga, Ontario, Canada
NCT00116883
- Conditions
- Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +7 more
- Locations
-
- GSK Investigational Site Hot Springs, Arkansas, United States
- GSK Investigational Site Little Rock, Arkansas, United States
- GSK Investigational Site Long Beach, California, United States
- GSK Investigational Site Jacksonville, Florida, United States
NCT00159523
- Conditions
- Asthma, Bronchial Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +19 more
- Locations
-
- Dep of Public health and general Practice Trondheim, Norway
NCT00762983
- Conditions
- Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +16 more
- Locations
-
Not specified
Completed
Postmarketing Surveillance to Investigate the Safety and Efficacy Information of Alesion® Tablet
NCT02238223
- Conditions
- Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +7 more
- Locations
-
Not specified